Key points are not available for this paper at this time.
The dicationic 4-ammonio-substituted imidazolium salt (2·H)(OTf)2 is readily obtained from its 4-amino-substituted imidazolium precursor (1·H)(OTf) by methylation of the exocyclic nitrogen. The cationic NHC (2)(OTf) is generated in situ by deprotonation of (2·H)(OTf)2 with 1 equiv of potassium bis(trimethylsilyl)amide and is trapped with sulfur or selenium. The direct linkage of the cationic ammonium moiety to the carbenic heterocycle through a σ bond has a profound effect on the electronic properties of the NHC by significantly decreasing its σ-donor ability and, to a lesser extent, increasing its π-acidity. These features make the 4-ammonio-substituted NHC 2+ an overall weak electron donor. To evaluate the coordination abilities of carbene 2+, several transition-metal complexes supported by this ligand have been prepared, including the cationic rhodium(I) complexes RhCl(cod)(2)(OTf) and RhCl(CO)2(2)(OTf), the cationic palladium(II) complexes PdCl(η3-allyl)(2)(OTf) and PdCl2(CH3CN)(2)(OTf), the zwitterionic palladium(II) complex PdCl3(2), and the tricationic silver(I) complex Ag(2)2(OTf)3.
Ruamps et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: